IBD patients should ‘not delay their infusion’ if stable with COVID-19 infection
Use of biologics did not worsen stable SARS-CoV-2 infection in patients with inflammatory bowel disease if given within 2 weeks of virus detection, according to research published in Clinical Gastroenterology and Hepatology.“IBD patients who are stable and asymptomatic after SARS-CoV-2 can safely undergo infusion of a biologic,” Nabeel Khan, MD, a gastroenterologist at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, told Healio.Using data from the Veteran Affairs Health System, Khan and colleagues conducted a retrospective cohort study to determine the impactRead More
